[SYRE] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -4.96%
YoY- -91.41%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 625 13,696 0 0 2,378 1,479 1,373 -12.28%
PBT -22,314 -6,738 -21,418 -18,019 -9,414 -6,632 -5,430 26.54%
Tax 9 92 0 0 0 0 0 -
NP -22,323 -6,830 -21,418 -18,019 -9,414 -6,632 -5,430 26.55%
Tax Rate - - - - - - - -
Total Cost 22,948 20,526 21,418 18,019 11,792 8,111 6,803 22.45%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -3,571.68 -49.87 0.00 0.00 -395.88 -448.41 -395.48 44.28%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -6.79 -2.60 -10.11 -13.72 -11.43 -11.75 -11.53 -8.44%
EPS Diluted -6.79 -2.60 -10.11 -13.72 -11.43 -11.75 -11.53 -8.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.